Arrhythmogenic right ventricular cardiomyopathy (ARVC) is described as a disease that has an autosomal dominant trait with reduced penetrance, that appears in dogs between two and eight years of age. Boxers are predisposed to ARVC. Some of the symptoms of ARVC are fainting, attacks of tachycardia -especially vetnricular tachycardia and sudden cardiac death. The aim of the study was to estimate the usefulness of 24-h Holter monitoring and the level of troponin I (cTnl) in examining the treatment of Boxers with ARVC. 24-h Holter monitoring and plasma concentrations of cTnI were carried out every three months after introducing anti-arrhythmic treatment (metoprolol prolongatum, sotalol or amiodaron). There was a significant correlation between the number of ventricular premature complexes (VPC) over a 24-h period and the level of cTnl. No correlation was found between the appearance of monitoring ventricular tachycardia (VT) and the level of cTnl. The presented results show the possibility to use cTnl to evaluate the efficacy of antiarrhythmia treatment in dogs with ARVC.
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Arrhythmogenic right ventricular cardiomyopathy (ARVC) is one of the heart diseases that can be found both in humans and animals. The first clinical description of this disease was described in 1736 1 , however, a more specific description of the etiology and development of the diseases was defined in the 80s of the twentieth century.
ARVC is described as a progressive replacement of myocardium cells with adipose cells and connective tissue cells as well as the emergence of ventricular heart rate disorders that lead to sudden cardiac death (SCD) [2] [3] [4] .
Boxers are predisposed to have ARVC. ARVC is described as a disease that has an autosomal dominant trait with reduced penetrance that appears in dogs two to eight years old 5 . This breed is used as a model for research on ARVC 6 . Single cases of ARVC were noticed in breeds such as Syberian Husky, Labrador Retriever and English Bulldog [7] [8] [9] . Cats do not show any predisposition correlated with sex, breed or age 5 . In spite of the development of many new diagnostic techniques like MRI, the foundation to recognize the ARVC is still finding fatty infiltrations in the myocardium of the right ventricle and the developing fibrosis tissue. As a result cardiomyocytes undergo apoptosis. The process initiates in the epicardium of the right ventricle. The highest level of fat (above 40%) is observed in the upperlateral wall of the right ventricle and the infundibulum 2 . Fatty infiltrations in dogs with ARVC are also observed in the left ventricle, intraventricular septum and even in the walls of the right and left atria 2, 10 . The level of fat and fibrous tissue is not correlated with the age, body weight or size of the heart. Lymphocytic infiltrations are also observed. According to Basso et al. they can be found in 60% of Boxers with ARVC and contain CD45, CD45RO-, CD43-positive lymphocytes 
MATERIAL and METHODS
The prospective study was performed on 11 Boxer dogs, aged from 5 to 11 years, of both sexes (7 male, 4 female). The observation time was between 4 and 19 months.
All of the dogs were clinically examined, had an echocardiography, electrocardiography, 24-h Holter monitoring, morphological and biochemistry blood tests performed. The echocardiography examination was conducted on the ALOKA 4000+ echocardiograph. A sector 5 MHz and 7.5 MHz probe was used. A right parasternal approach was used to carry out the echocardiography, and a long axis view of the left ventricle in motion mode was used for the observation. All dogs underwent ECG in a right lateral position on the BTL SD08 electrocardiograph machine equipped with a net filter and different frequencies of muscular filters. The electrodes were placed on the: right arm (red electrode), left arm (yellow electrode), right leg (black electrode) and left leg (green electrode) accordingly. The precordial leads were attached as follows: V1 was placed to the right of the sternum at the 5 th intercostal space, V2 -was placed directly to the left of the sternum, V4 -was placed to the left at the costochondrial junction at the 6 th intercostal space. A 24-h Holter monitoring was performed by an AsPECT 702 3-channel device. Single-use, self-adhesive electrodes were placed on the shaved skin of the thorax (Fig. 1) . The unit was stabilized between spatulas by a special protective cloth (Fig. 2 ).
Blood samples were collected after the clinical examination. The criteria to include the dogs in the study were: presence no less than 500 ventricular premature complexes (VPC) of right ventricular origin during 24 h and syncope 12 , no changes in the echocardiography test, no enlargement of the right ventricle, regional hypokinesis of the right ventricle 1 . The foundation of diagnosing ARVC is finding fatty infiltrations in the myocardium of the right ventricle and the development of fibrosis tissue. All the dogs had ARVC confirmed posthumously (Fig. 3) . 24-h Holter monitoring and plasma concentrations of cTnI were carried out every 3 months after beginning anti-arrhythmic treatment (metoprolol prolongatum -2 dogs, sotalol -7 dogs, 2 dogs did get in the past metoprolol, amiodaron-1 dog, next change to sotalol or mexiletine -1 dog, before the dog was treated by sotalol).
The correlation between VPC/24 h and cTnI was analyzed by using the R Spearman test. The testing was done based on the significance level of P<0.05.
The study was approved by the ethics committee of the University of Environmental and Life Sciences, Wroclaw, Poland.
RESULTS
Fainting was observed in 8 out of 11 Boxers. Seven dogs showed VPC in resting ECG (Fig. 4) . In the first Holter monitoring all the dogs had right sided VPC, between 1 473 and 27 651 during 24 h. In 10 out of 11 dogs the VPC doubled or tripled. In 9 out of 11 dogs in the first Holter monitoring ventricular tachycardia (VT) was observed and one of these dogs had a polymorphic tachycardia. In 3 cases there was a historical sudden cardiac death (SCD) in the parents or siblings. Five dogs died suddenly. A moderate enlargement of the right ventricle was observed in echocardiography in 6 out of 11 dogs, hypokinesis in 3 out of 11 dogs (Fig. 5) . The results of the 24-h Holter monitoring and the level of cTnl is presented in Table 1 . There was a significant correlation between the number of VPC during 24 h and the level of cTnl (r=0.82; P<0.05) in the following tests (Fig. 6) . No correlation was found between the appearance of VT and the level of cTnl. There were no changes in the biochemical and morphological blood parameters.
DISCUSSION
The presented results show the possibility to use cTnl to evaluate the efficacy of anti-arrhythmia treatment in dogs with ARVC, especially that for determine the level of cTnI human tests can be used In the study group 72% of dogs showed fainting. SCD was the first and only symptom of the disease 7 . In the study group 45% of dogs showed SCD and 27% of dogs had a positive anamnesis towards SCD.
Cardiac Troponin I (cTnI) is a protein belonging to the troponin-myosin complex in cardiomyocytes. Its 13 . In dogs with ARVD enzyme elevations is connection with myocyte appoptosis 15 .The number of premature accelerations can vary in dogs with ARVC, which is confirmed in the study 16 . In this study the correlation between VPC/24 h and the concentration of cTnI was observed. Similar observations were done by Baumwart RD et al. 17 . Also, in humans with ARVC increase in cTnI without coronary artery stenosis in coronary angiogram was recorded 18, 19 . A significant increase in the concentration of cTnI may also be a signal of structural alteraions during "hot phases" of the ARVC, as described in humans 20 .
A lack of correlation between VT and cTnl may be related to a short term prevalence of Troponin I in the serum after its release from the myocardium, which lasts a maximum of approximately 14 days. There is a possibility to "overlook" the increase of cTnl, if the damage of the myocardium was single episode and VT was occasionally. A permanent high level of cTnl is the result of progressive damage of the myocardium, permanent VPC and periodic VT. cTnI level rise occurred five days after the VT episodes 20 . In this study cTnI level was measured once per three month. In this research scheme noticing the growth after an episode of VT is difficult or even impossible. The aim of the treatment is to increase the threshold of cardiomyocytes which will lead to a smaller number of VPCs and the possibility of VT appearance and ventricular fibrillation (VF). In the presented study it is confirmed that if the anti-arrhythmia treatment was efficient, no matter what the acting substance was, it did lower the number of VPC and the level of cTnl.
Polyunsaturated fatty acids and L-carnitine are used as supportive treatment to stabilize the membranes of cardiomyocytes. It is not possible to prevent heart rate disorders during ARVC and if the changes progress, a life NOSZCZYK-NOWAK, PASLAWSKA, CEPIEL STASZCZYK, JANISZEWSKI, NICPON threatening arrhythmia may occur. In humans electrical radio frequency ablation is used to reduce the number of arrhythmogenic centers as one of the ways of treatment 21 . To terminate ventricular fibrillation implantable cardioverter defibrillators are used. This type of therapy to prevent sudden cardiac death in dogs with ARVC was presented by Nelson et al., however the cost of the unit is very high 22 . Latest research indicates the beneficial effect of preloadreducing therapy in progression of ARVC, however, these results need to be confirmed in clinical trials 23 . In case of heart failure adequate treatment is used. The prognosis for dogs with ARVC is not optimistic. New guidelines ARVD 2012: Diagnostic Challenges and Treatment, which pays attention to the fact that excessive exercise appears to exacerbate the manifestation in the disease in experimental animals, were published this year 24 .
Monitoring the level of cTnl allows to check the efficacy of anti-arrhythmia treatment by lowering the number of VPC, but does not allow to forecast the risk of SCD related with VT and VF.
